The optimum time to search for environmental factors which precipitate rheumatoid arthritis should be during the earliest stages of the disease.' Indeed immediate responses to environmental factors might be found in affected joints and precede the autoimmune response (rheumatoid factors) which is thought to precipitate the chronicity of rheumatoid disease.2
With a model of simple diffusion across the synovial membrane evidence has been obtained for synovial synthesis of immunoglobulins and rheumatoid factors. 3 " The concentration of a plasma protein in synovial fluid depends on the molecular size of that protein, on synovial membrane permeability which increases with inflammation, and on whether the protein is locally synthesised in the synovial membrane. With the use of plasma proteins whose site of synthesis is the liver, namely, orosomucoid, transferrin, ceruloplasmin and a2-macroglobulin, a linear relationship has been shown between log synovial fluid to serum concentration ratios and log molecular weight.3 When diffusion of immunoglobulins and IgM rheumatoid factor was calculated, concentrations were higher than predicted, indicating local synthesis of these components.3 4 We report here evidence, based on this diffusion model, of local synthesis of immune complex constituents and rheumatoid factors in 2 groups of patients, those with definite RA and those with unclassified inflammatory arthritis (IA SF:S ratios were estimated from a linear relationship between the logarithm of the SF: S ratio and the logarithm of molecular weight as demonstrated by Kushner and Somerville3: log (SF:S ratio) = patient 'factor' + ('slope' constant x log (molecular weight)) where the patient 'factor' is the distinct intercept on the vertical axis for each patient, and the 'slope' constant is the same for each patient. Fig. 1 gives a sample of the data plotted on logarithmic scales. The patient 'factors'-constant for each patient-and the 'slope' constant were estimated by means of least squares analysis on the logarithms of the SF:S ratios and the molecular weights of the 3 marker proteins.
Results
Clinical features. Patients were classified as RA if they had acquired 5 or more ARA criteria6 at the end of the study, whether or not a diagnosis could be made when samples were taken. All the IA patients (Table 1) and not from the time of diagnosis of RA; those with symptoms for more than one year had suffered symptoms ranging from 13 months to 17 years.
Estimated diffiusion from plasma. The concentrations of immune complexes, IgM RF and IgG RF in synovial fluid were plotted against the concentrations estimated to have diffused from plasma into synovial fluid across the synovial membrane (Fig. 2) . Values on or near the 450 dashed line indicate that the concentration in joint fluid was similar to the estimated Table 1 Clinical data for rheumatoid arthritis (RA) and Estimates of local synthesis. The percentage of patients with their estimated concentrations of locally synthesised synovial fluid constituents are shown in Fig. 3 . The 4 patients with small 'negative' estimates for immune complex synthesis were included with those having estimates of 1% to 10% Clq binding activity. Considerable amounts of immune complexes (> 20% Clq binding activity) were estimated to be formed locally by the majority of RA patients 
Discussion
These results suggest that immune complexes are formed or trapped in the inflamed joints of many arthritis patients in the early months of symptoms and that these IC are unrelated to rheumatoid factors. Local synthesis of rheumatoid factors appears to take place mainly in the later months and then almost exclusively in patients with definite RA. This confirms and extends our preliminary studies. ' The evidence is based on a model of simple diffusion across the synovial membrane, described by Kushner and Somerville.' However, we have modified their statistical approach by introducing a patient 'factor' specific to each patient which represents that patient's average synovial permeability. This enabled us to obtain estimates of SF: S ratios for immune complexes and rheumatoid factors specific to each patient rather than making global estimates for groups of patients. This model is appropriate to assess local synthesis of rheumatoid factors of both IgG and 1gM class,4 because it has been convincingly shown that the synovial membrane offers no barrier to transport of rheumatoid factors in either direction, from plasma to synovial space or vice versa. ' On the other hand the diffusion model may not be as suitable or accurate for immune complexes. First, the antigenic specificity of antigen-antibody complexes may differ in serum and synovial fluid; the specificity of the Clq binding complexes detected in both compartments is unknown. Secondly, the estimates of IC diffused from plasma are based on a molecular size of 1 x 106 for these complexes and would be less accurate for larger or smaller complexes. If the complexes were larger, the amount diffused would be underestimated. In rheumatoid sera some complexes containing IgG have a molecular weight of 4 x 107, although the greatest proportion are approximately 2 x 10' (Svehag, personal communication). And Clq binding complexes in synovial fluids are greater than 19S from gel filtration experiments (our unpublished data). Nevertheless, it is worth noting that our estimate of the 'slope' constant in the log-linear relationship between SF: S ratio and molecular weight is -0-18. This implies that a doubling of molecular weight leads to a reduction in SF: S ratio of only 12% (2" 1= 088). In other words the estimation of concentration diffused from plasma is relatively insensitive to the errors introduced by inaccurate molecular weight determinations.
A third source of error might be the inability of large complexes to diffuse across the synovial membrane. Evidence that Clq binding immune complexes present in the early stages of disease are unrelated to rheumatoid factors is suggested by the lack of correlation between concentrations of the locally synthesised components. This is supported by previous studies in which circulating immune complexes were detected in the first months of symptoms in patients with unclassified arthritis and also in patients developing RA before their disease could be diagnosed as definite and before rheumatoid factor levels were raised." Thus we have further evidence that in RA patients immune complexes appear both in the circulation and in inflamed joints before evidence of autoimmunity appears. We are currently attempting to determine the composition of these complexes by physicochemical methods. 
